Cipla liquidates wholly owned subsidiary as part of internal restructuring

Published On 2021-03-08 08:29 GMT | Update On 2021-03-08 08:29 GMT

New Delhi: Drug major Cipla on Saturday said it has voluntarily liquidated a wholly-owned step-down subsidiary.

This liquidation was a part of internal reorganisation and it will not affect performance or revenue of the company, Cipla said in a BSE filing.

"Cipla (UK) Ltd, a wholly owned subsidiary of Cipla (EU) Ltd and a wholly -owned step down subsidiary of the company, has been voluntarily liquidated with effect from March 5, 2021," the Mumbai-based drug firm said.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Cipla liquidates wholly owned subsidiary as part of internal restructuring

Similar News